FSSAI send notices to Dr Reddy's, Nestle Health Science, Amazon, Flipkart over misleading protein supplement
The Food Safety and Standards Authority of India (FSSAI) has sent notices to companies, including Dr Reddy's and Nestle Health Science, regarding products which can possibly mislead consumers regarding its health benefits. It issued notices for non-compliant advertising and misleading claims.
The Food Safety and Standards Authority of India (FSSAI) has issued notices to several companies for selling misleading health supplement products. The regulator took action against Dr Reddy's, Nestle Health Science, Tirupati Wellness, Flipkart, Amazon, and Netmeds for non-compliant advertising and claims made for the product CELEVIDA GLP on e-commerce platforms.
FSSAI stated that the claims printed on the packaging, such as muscle strength, immunity support, and energy metabolism, could potentially mislead consumers about the product's health benefits. The regulator highlighted that the product was advertised as high protein support for lean muscle preservation during GLP-1/GIP therapies, with claims associating its consumption with these therapies and lean muscle preservation.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
